Eli Lilly, Novo Nordisk compete for lead in India’s obesity drug market (Soban News)

Novo’s strategy emphasises price cuts and accelerated launches, while Lilly’s products benefitted from hitting the market early​Novo’s strategy emphasises price cuts and accelerated launches, while Lilly’s products benefitted from hitting the market early ​Latest News [ SOBAN NEWS: International and National ]